Position history for BlackRock, Inc.'s holdings in BRIGHT MINDS BIOSCIENCES INC
BlackRock, Inc. holds 621,933 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), worth $45.4M as of 2026-Q1. The position was increased (+57.8% shares). DRUG represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$45.4M
Current Shares
621,933
Total Value Change
+$45.4M
Total Shares Change
+621,932
Other major holders of DRUG: JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C.
Increased |
| 621,933 |
+57.8% |
| $45.4M |
| 0.0% |
| $80.00 |
42 |
| 2025-Q4 | Increased | 394,043 | +68.3% | $30.8M | 0.0% | $75.85 | 43 |
| 2025-Q3 | Increased | 234,118 | +11.7% | $14.2M | 0.0% | $57.45 | 31 |
| 2025-Q2 | Increased | 209,677 | +308x | $5.5M | 0.0% | $23.27 | 44 |
| 2025-Q1 | Increased | 678 | +677x | $24,455 | 0.0% | $36.50 | 21 |
| 2024-Q4 | New | 1 | - | $36 | 0.0% | $36.86 | 17 |